Australia vs Latvia: Proportion of isolates with decreased susceptibility or resistance
Australia
0.0666
in 2018
Latvia
0
in 2018
Australia rank
24th
Latvia rank
25th
Proportion of isolates with decreased susceptibility or resistance over time
- Australia
- Latvia
How they compare
Australia currently reports 0.0666 against 0 in Latvia, a difference of 0.0666.
The two have swapped places 2 times across 10 shared years of data; in 2009 it was Australia ahead.
Australia ranks 24th and Latvia ranks 25th of 51 countries.
Across the 2 decades both report, Australia averaged higher in 1 and Latvia in 1.
Head to head by decade
| Decade | Australia | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0317 | 0 | 0.0317 | Australia |
| 2010s | 0.4001 | 0.5773 | 0.1772 | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Australia or Latvia?
- Australia, at 0.0666 against 0 in Latvia as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Australia and Latvia?
- 0.0666, with Australia ahead.
- How many years of comparable data are there for Australia and Latvia?
- 10 years are reported by both, from 2009 to 2018.
- How do Australia and Latvia rank globally for proportion of isolates with decreased susceptibility or resistance?
- Australia ranks 24th and Latvia ranks 25th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.